Press Release Mar 04 2026
Filed with NSE · · 3 pages · English
Earlier from Aurobindo Pharma
- Press Release Feb 26 2026
- Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
- Press Release Feb 13 2026
- Press Release Feb 09 2026
- Kargo.ai Raises $42M Series B to Scale Global Warehouse Deployment with Enterprise Clients
Later from Aurobindo Pharma
- Press Release Apr 06 2026
- Press Release Apr 07 2026
- Press Release Apr 17 2026
- Press Release May 21 2026
- Press Release Jun 03 2026
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma